Please login to the form below
United Therapeutics
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of United Therapeutics' 2013 cardiovasular sales performance.
Delay for inhaled hypertension treatment
United Therapeutics has announced it is likely to face regulatory delays for the inhaled version of its hypertension drug Remodulin. ... Shares of United Therapeutics sank $2 (or 3 per cent) to $66.28 in pre-market activity.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- STEM Healthcare founder Rob Wood secures a 25% stake in performance-io
- Sinopharm’s COVID-19 vaccine scores approval in China
- Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU
- UPDATED: Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- Roche, Genentech partner with The Weill Neurohub on ten-year neuroscience collaboration
- EMA begins rolling review process for Sputnik V COVID-19 vaccine
- MHRA to fast-track vaccines modified for new COVID-19 variants
- Pfizer’s ALK inhibitor Lorbrena scores expanded FDA approval for first-line NSCLC
- Syneos Health Communications announces senior hires to Europe-based team
- Live Webinar: Search Listening as a Tool to Inform Brand Strategy & Enable Patient-Centricity
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
- A cultural shift in clinical research
- Research organisations across the board are experimenting with new technologies...
Quick links
Infographics
